2 Drug Discovery companies in New York.
By the Numbers
Output Biosciences
New York
Output Biosciences pioneers Biologically-Aware Generative AI and Large Biological Models to predict, understand, and program living systems across scales, enabling new medicines and diagnostics. Founded by Adi Mashiach, MD, and Mirella Mash
Serinus Biosciences
Serinus Biosciences is a seed-stage TechBio using a knowledge-primed AI engine to model cancer molecule function in tumor cells. Backed by Y Combinator and Illumina Ventures, its lead program targets a first-in-class PPI with a $20B US mark
